Drugs / Fasitibant
Fasitibant
also known as
Chlorure de fasitibant · Cloruro de fasitibant · Fasitibant cation · FASITIBANT CHLORIDE · Fasitibant ion · MEN-16132 FREE BASE · MEN16132
Small molecule targets BDKRB2 via inhibition
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02205814 | Apr 2014 → Jan 2015 | osteoarthritis, knee | Menarini Group | Completed | No outcome recorded |
| Phase 2 | NCT01091116 | Mar 2010 → Feb 2011 | osteoarthritis, knee | Menarini Group | Completed | Missed primary |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fasitibant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02205814 ↗ |
| Known as | Chlorure de fasitibant | ChEMBL registry synonym — accepted as the source's own label CHEMBL218427 ↗ |
| Known as | Cloruro de fasitibant | ChEMBL registry synonym — accepted as the source's own label CHEMBL218427 ↗ |
| Known as | Fasitibant cation | ChEMBL registry synonym — accepted as the source's own label CHEMBL218427 ↗ |
| Known as | FASITIBANT CHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL218427 ↗ |
| Known as | Fasitibant ion | ChEMBL registry synonym — accepted as the source's own label CHEMBL218427 ↗ |
| Known as | MEN-16132 FREE BASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL218427 ↗ |
| Known as | MEN16132 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01091116 ↗ |
| Action | Inhibit | “bradykinin B2-receptor antagonist” NCT01091116 ↗1“Bradykinin B2 receptor antagonist” CHEMBL218427 ↗ |
| Modality | Small molecule | — CHEMBL218427 ↗ |
| Route | Other | “Intra-articular administration” NCT01091116 ↗ |
| Target | BDKRB2 | “Bradykinin B2 receptor antagonist” CHEMBL218427 ↗ |